In models of acute myeloid leukemia (AML), curcumin appears to operate through a non-canonical inflammasome pathway by upregulating interferon-stimulated gene ISG3, thereby activating NLRC4, AIM2, and IFI16 inflammasome sensors. Here, NLRC4 is linked to acute myeloid leukemia.